Farm Comunitarios. 2013 Dec 19;5(4):147-151

Tools for evaluating the suitability of prescriptions for the elderly

Mud Castelló F1, Mud Castelló S1, Rodríguez Moncho MJ1, Ivorra Insa MD2, Ferrándiz Manglano ML2
1. Farmacéuticos comunitarios en Ondara (Alicante) 2. Departamento de Farmacología, Facultad de Farmacia de la Universidad de Valencia
Mud F, Mud S, Rodríguez MJ, Ivorra MD, Ferrándiz ML. Tools for evaluating the suitability of prescriptions for the elderly. Farm Comunitarios. 2013 Dec 19;5(4):147-151
Abstract : 

Ageing is a complex process. As we age, significant physiological changes occur and the incidence of multiple organic and systemic pathologies increases. Older patients are prescribed a high number of drugs. The elderly are also the group with the greatest number of medical appointments and hospital admissions. Seniors are the population group with the highest level of polymedication. Polymedication generates a high cost for the National Health System and can also increase the number of adverse reactions or interaction with medications. The inappropriate prescribing of drugs is a frequent problem among elderly people, which contributes to increasing the risk of ADR. In recent years, several tools have been developed to detect potentially inappropriate prescriptions in older adults. The aim of this review is to describe two of these tools: the North American BEERS criteria and the European STOPP (Screening Tool of Older Person’s Prescriptions)/START (Screening Tool to Alert doctors to Right i.e. appropriate, indicated Treatment) criteria. The STOPP criteria offer the added value of detecting not only inappropriate prescription of certain drugs, but also the lack of prescription of indicated drugs. The STOPP/START criteria can become a good tool for improving prescriptions among older patients.

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Share

-

Related contents

Manual for authors

Journal Information